|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/08 | (2006.01) |
| A61K 9/0019 | (2013.01) | ||
| A61K 47/18 | (2017.01) | ||
| A61K 38/2278 | (2013.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61K 38/26 | (2013.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 9/08 | (2013.01) | ||
| A61K 47/20 | (2013.01) |
| (11) | Patento numeris | 3345593 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18152952.0 |
| Europos patento paraiškos padavimo data | 2010-11-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-09-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 102009052832 | 2009-11-13 | DE | |
| 102010011919 | 2010-03-18 | DE |
| (72) |
BRUNNER-SCHWARZ, Anette , DE
MÜLLER, Werner , DE
SIEFKE-HENZLER, Verena , DE
|
| (73) |
Sanofi-Aventis Deutschland GmbH ,
Brüningstraße 50, 65929 Frankfurt,
DE
|
| (54) | PHARMAZEUTISCHE ZUSAMMENSETZUNG UMFASSEND DESPRO36EXENDIN-4(1-39)-LYS6-NH2 UND METHIONIN |
| PHARMACEUTICAL COMPOSITION COMPRISING DESPRO36EXENDIN-4(1-39)-LYS6-NH2 AND METHIONINE |